نتائج البحث

Voriconazole plasma concentrations and dosing in paediatric patients below 24 months of age.

• Authors : Gastine, Silke E.¹ (AUTHOR); Rauwolf, Kerstin K.² (AUTHOR); Pieper, Stephanie² (AUTHOR)

• Source: Mycoses. Nov2023, Vol. 66 Issue 11, p969-976. 8p.

تفاصيل العنوان

Optimal timing for therapeutic drug monitoring of voriconazole to prevent adverse effects in Japanese patients.

• Authors : Hanai, Yuki¹ (AUTHOR) ‐u.ac.jp; Ueda, Takashi² (AUTHOR); Hamada, Yukihiro³ (AUTHOR)

• Source: Mycoses. Dec2023, Vol. 66 Issue 12, p1035-1044. 10p.

تفاصيل العنوان

Voriconazole plus flucytosine is not superior to amphotericin B deoxycholate plus flucytosine as an induction regimen for cryptococcal meningitis treatment.

• Authors : Handan Zhao^1,2; Yanqiu Lu³; Shan Li⁴

• Source: Mycoses. Jan2024, Vol. 67 Issue 1, p1-8. 8p.

تفاصيل العنوان

Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis.

• Authors : Khattab, Fathia¹ (AUTHOR); Elkholy, Basma M.¹ (AUTHOR) ; Taha, Mohamed² (AUTHOR)

• Source: Mycoses. Dec2022, Vol. 65 Issue 12, p1194-1201. 8p.

تفاصيل العنوان

Contribution of voriconazole N‐oxide plasma concentration measurements to voriconazole therapeutic drug monitoring in patients with invasive fungal infection.

• Authors : Boglione‐Kerrien, Christelle¹ (AUTHOR) christelle.boglione‐kerrien@chu‐rennes.fr; Morcet, Jeff² (AUTHOR); Scailteux, Lucie‐Marie³ (AUTHOR)

• Source: Mycoses. May2023, Vol. 66 Issue 5, p396-404. 9p.

تفاصيل العنوان

Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018–2021) and application of single‐site epidemiological cutoff values to evaluate amphotericin B activity

• Authors : Pfaller, Michael A.^1,2 (AUTHOR); Carvalhaes, Cecilia G.¹ (AUTHOR); Castanheira, Mariana¹ (AUTHOR) mariana‐

• Source: Mycoses. Oct2023, Vol. 66 Issue 10, p854-868. 15p.

تفاصيل العنوان

The influence of CYP2C19 polymorphisms on voriconazole trough concentrations: Systematic review and meta‐analysis.

• Authors : Zhang, Ying^1,2 (AUTHOR); Hou, Kelu¹ (AUTHOR); Liu, Fang³ (AUTHOR)

• Source: Mycoses. Aug2021, Vol. 64 Issue 8, p860-873. 14p.

تفاصيل العنوان

The cost‐effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain.

• Authors : Azanza, José Ramón¹ (AUTHOR) ; Grau, Santiago² (AUTHOR); Vázquez, Lourdes³ (AUTHOR)

• Source: Mycoses. Jan2021, Vol. 64 Issue 1, p66-77. 12p.

تفاصيل العنوان

Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.

• Authors : Bongomin, Felix^1,2 ; Maguire, Niamh³; Moore, Caroline B.³

• Source: Mycoses. Mar2019, Vol. 62 Issue 3, p217-222. 6p.

تفاصيل العنوان

Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan.

• Authors : Hamada Y; Department of Pharmacy, Tokyo Women's Medical University Hospital, Tokyo, Japan.; Ueda T

Subjects: Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/administration & dosage ; Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/adverse effects ; Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/therapeutic use

• Source: Mycoses [Mycoses] 2020 Aug; Vol. 63 (8), pp. 779-786. Date of Electronic Publication: 2020 Jun 25.Publisher: Grosse Verlag Country of Publication: Germany NLM ID: 8805008 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان